Compare McKesson Corporation (MCK) vs Star Bulk Carriers Corp (SBLK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
McKesson Corporation vs Star Bulk Carriers Corp — how do they compare? McKesson Corporation trades at $937.1 (market cap $108.46B), while Star Bulk Carriers Corp trades at $29.7 (market cap $3.54B). The key difference: McKesson Corporation is far larger — about 30.6× Star Bulk Carriers Corp's market cap, and Star Bulk Carriers Corp pays the higher dividend (6.17%). Which is the better fit depends on your goals — on Pluang, investors hold McKesson Corporation for 74 Days and Star Bulk Carriers Corp for 24 Days on average.
| MCK | SBLK | |
|---|---|---|
Market Cap | $108.46B | $3.54B |
Volume | 712,607 | 1,437,622 |
Sector | Health | Industrials |
52-Week High | $995.69 | $32.49 |
52-Week Low | $725.17 | $16.79 |
Typical Hold Time | 74 Days | 24 Days |
Enterprise Value | $115.00B | $4.22B |
Dividend Yield | 0.4% | 6.17% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
McKesson Corporation (MCK) trades at $938.84, up 3.13% with strong technical momentum and bullish analyst sentiment. The stock shows consistent earnings beats with Q2 2026 EPS of $9.93 exceeding expectations of $9.56. Recent news highlights the extension of McKesson's pharmaceutical distribution agreement with CVS Health through 2032, reinforcing long-term revenue visibility. Revenue growth remains robust, climbing from $264.0B in 2022 to $359.1B in 2025, though net margins are thin at 1.12%.
The outlook is positive with 81% analyst buy ratings and a $956.43 consensus price target. Key risks include margin pressure from drug pricing policies and high current liabilities of $61.60B. The stock's valuation at 24.95x P/E appears reasonable given earnings growth projections, but investors should monitor debt levels and regulatory developments in healthcare distribution.
Star Bulk Carriers (SBLK) trades at $29.70, up slightly by 0.03% today, with a bullish technical signal from moving averages and a neutral stance from oscillators. The company shows strong profitability with a net income margin of 23.87% and has beaten earnings estimates for the last three quarters. Recent news highlights robust Q2 results, a $0.90 dividend for H2 2026, and significant insider buying, reflecting confidence in the shipping sector's momentum.
The outlook for SBLK is positive, supported by earnings beats, a shareholder-friendly dividend policy, and analyst consensus leaning buy. Risks include exposure to volatile shipping rates and macroeconomic pressures on global trade. Investors may find value in its attractive valuation multiples and strong cash flow generation, but should monitor freight rate trends and competitive dynamics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →About Star Bulk Carriers Corp
Star Bulk Carriers Corp. is a global shipping company specializing in the seaborne transportation of dry bulk commodities. The company owns and operates a large fleet of bulk carriers, primarily transporting major commodities such as iron ore, coal, and grain. SBLK focuses on the Capesize, Post Panamax, and Kamsarmax vessel segments, providing critical logistical services to commodity producers and consumers worldwide.
Read more on SBLK →
